Genex Pharmaceutical Inc

Over The Counter Market:GENXUnited States

Genex Pharmaceutical, Inc. (Genex) was considered a development-stage company prior to June 17, 2004. Genex was a start-up, Internet-based fulfillment company with offices in Vancouver, British Columbia, Canada. On June 8, 2004, Genex entered into a share purchase agreement with Tianjin Zhongjin Biology Development Co., Ltd. (Zhongjin). On June 17, 2004, the stock purchase made pursuant to the share purchase agreement was consummated and Zhongjin became a wholly owned subsidiary of Genex. Zhongjin engages in the business of producing and distributing Reconstituted Bone Xenograft (RBX), which is considered a medical device that accelerates bone healing. Zhongjin solely markets its medical devices to hospitals in China. Zhongjin distributes its medical devices to more than 500 hospitals in 30 provinces throughout China. Zhongjin also markets its medical devices to medical device customers in China that are not hospitals.

Contact Information

Headquarters

1801 Guangyin Building Youyibeilu, Hexi DistrictTIANJIN, TNJ, China 300074

Phone

222-337-0440

Fax

222-337-9585

Executives

Chairman of the Board, President, Chief Executive Officer

Song Fuzhi

Chief Financial Officer, Treasurer

Zhang Shuli

Secretary

Sufen Ai